Archives

by in
Entry Author Date Location
Overstreet, Winner in Startup Tax Battle, Gets $2M for AdverseEvents 04/16/14 San Francisco
AAVLife Gets $12M to Bring Gene Therapy to Rare Ataxia 04/15/14 Boston
East Coast Biotech Roundup: Agios, Spero, Cerulean, & More 04/11/14 Boston
Cerulean Limps into Nasdaq Debut With $7 Per Share IPO 04/10/14 Boston
Agios Taps Wall Street Off Early Data, Aims For $75M 04/10/14 Boston
Spero Emerges With $3M, Backing From Roche, & Plans to Disarm Bugs 04/09/14 Boston
Announcing Napa Summit 2014: Get An Invite to Xconomy’s Elite Confab 04/08/14 National
Alkermes Scores Phase 3 Win for Long-Lasting Schizophrenia Drug 04/08/14 Boston
Agios’s Blood Cancer Drug Shines in First Clinical Test 04/06/14 Boston
East Coast Biotech Roundup: Berg, Forma/Celgene, Intarcia, & More 04/04/14 Boston
Backed By a Billionaire, Berg Pharma Aims to Speed Drugmaking 04/02/14 Boston
ZappyLab Creates Social Apps for Biologists 04/01/14 San Francisco
Forma Gets $225M More, And a Potential Buyout, From Celgene 04/01/14 Boston
Xconomy Boston’s Top Stories of Q1 2014: Editor’s Picks 03/31/14 Boston
FDA Lifts Clinical Hold on Curis Cancer Drug, Shares Surge 03/31/14 Boston
Learn the Future of New England Innovation: Announcing Boston 2034 03/31/14 Boston
East Coast Biotech Roundup: Neurophage, Boston Biotech, Insmed, & More 03/28/14 Boston
Syndax Plots $69M IPO For Cancer Drug’s Stretch Run 03/27/14 Boston
What’s Hot in Boston Biotech: Here’s the Agenda for April 16 03/27/14 Boston
Neurophage Nabs $17M More to Hunt Down Brain Plaques 03/25/14 Boston
East Coast Biotech Roundup: Proteon, Ataxion, NY Genome/Watson, & More 03/21/14 Boston
NinePoint Gets $34M From Corning, Others, For Medical Imaging Tech 03/20/14 Boston
Proteon, Looking Past Ill-Fated Novartis Deal, Goes it Alone 03/18/14 Boston
East Coast Biotech Roundup: ImmusanT, NY Disruptors, Tesaro, & More 03/14/14 Boston
Sage Therapeutics Grabs $38M More For CNS Drugs 03/13/14 Boston
Partnership with AnaptysBio Gives Tesaro Entrée to Immuno-Oncology 03/13/14 San Diego
Get a Shot, Have Some Bread: ImmusanT’s Plan For a Celiac Vaccine 03/11/14 Boston
Brushing Off Clinical Setback, Cerulean Tees Up $75M IPO 03/10/14 Boston
East Coast Biotech Roundup: VentriNova, RainDance, Biogen, & More 03/07/14 Boston
Farewell, Xconomy Readers. I’m Going to Climb a New Mountain 03/05/14 National
Page 1 of 82 next page »